Benjamin Besse

Benjamin Besse

UNVERIFIED PROFILE

Are you Benjamin Besse?   Register this Author

Register author
Benjamin Besse

Benjamin Besse

Publications by authors named "Benjamin Besse"

Are you Benjamin Besse?   Register this Author

100Publications

3091Reads

31Profile Views

Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?

Immunotherapy 2019 Sep 30;11(13):1149-1160. Epub 2019 Jul 30.

Department of Cancer Medicine, Gustave Roussy Institute, F-94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0071DOI Listing
September 2019

Letter to the Editor about Sorich et al.

J Thorac Oncol 2019 Sep;14(9):e209

Cancer Medicine Department, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.022DOI Listing
September 2019

Treatment duration of checkpoint inhibitors for NSCLC.

Lancet Respir Med 2019 Aug 7. Epub 2019 Aug 7.

Gustave Roussy, Department of Cancer Medicine, 94805 Villejuif, France; Université Paris-Saclay, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30192-4DOI Listing
August 2019

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Lung Cancer 2019 Aug 13;136:145-147. Epub 2019 Aug 13.

The University of Manchester, Division of Cancer Sciences, The Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.007DOI Listing
August 2019

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.

Eur J Cancer 2019 Jul 13;116:182-189. Epub 2019 Jun 13.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.05.019DOI Listing
July 2019

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC.

J Thorac Oncol 2019 Jul 11. Epub 2019 Jul 11.

Cancer Medicine Department, Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.001DOI Listing
July 2019

Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?

J Thorac Oncol 2019 Jun 23;14(6):963-967. Epub 2019 Apr 23.

Gustave Roussy, Cancer Medicine Department, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.031DOI Listing
June 2019

Multiple colic intussusceptions.

Clin Case Rep 2019 Jun 11;7(6):1265-1266. Epub 2019 May 11.

Department of Oncologic Digestive Surgery Gustave Roussy Institute Villejuif France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.2181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552947PMC
June 2019

Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.

J Thorac Oncol 2019 Jun 11. Epub 2019 Jun 11.

Department of Intensive Care and Oncological Emergencies and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.037DOI Listing
June 2019

Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In Reply.

JAMA Oncol 2019 May;5(5):744

Department of Cancer Medicine, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0138DOI Listing
May 2019

Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?

Eur J Cancer 2019 May 6;113:28-31. Epub 2019 Apr 6.

Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, F-94805, France; CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049193018
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2019.02.016DOI Listing
May 2019

Exploring the optimal use of alectinib.

Lancet Respir Med 2019 May 15;7(5):373-374. Epub 2019 Apr 15.

Cancer Medicine Department, Gustave Roussy Cancer Center, F-94805, Villejuif, France; University Paris-Sud, Faculty of Medicine, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30117-1DOI Listing
May 2019

Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?

J Thorac Oncol 2019 Mar;14(3):328-331

Medical School, Paris-Saclay University, Paris-Sud University, Le Kremlin Bicêtre, France; Drug Development Department (DITEP), Gustave Roussy Institute, Paris Saclay University, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.011DOI Listing
March 2019

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol 2019 Jan 4;6(1):e48-e57. Epub 2018 Dec 4.

Service de Médecine Interne and Immunologie Clinique, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France; Université Paris Sud, Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes, INSERM, Le Kremlin-Bicêtre, France; Division d'Immunovirologie, Commissariat à l'Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30175-3DOI Listing
January 2019

Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer.

Eur J Cancer 2019 Jan 5;106:144-159. Epub 2018 Dec 5.

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Medical Oncology, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183145
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.002DOI Listing
January 2019

Hyperprogressive disease: recognizing a novel pattern to improve patient management.

Nat Rev Clin Oncol 2018 12;15(12):748-762

Département d'Innovation Thérapeutique et des Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41571-018-0111-2
Publisher Site
http://dx.doi.org/10.1038/s41571-018-0111-2DOI Listing
December 2018

Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy.

Transl Lung Cancer Res 2018 Dec;7(6):647-660

Department of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://tlcr.amegroups.com/article/view/24555/18844
Publisher Site
http://dx.doi.org/10.21037/tlcr.2018.09.22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249615PMC
December 2018

Prolonged Leptomeningeal Responses with Brigatinib in Two Heavily Pretreated ALK-Rearranged Non-Small Cell Lung Cancer Patients.

J Thorac Oncol 2018 11 6;13(11):e215-e217. Epub 2018 Jun 6.

Medical Oncology Department, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.033DOI Listing
November 2018

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?

Nat Rev Clin Oncol 2018 11;15(11):694-708

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0081-4DOI Listing
November 2018

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy.

Int J Clin Pharm 2018 Oct 9;40(5):1265-1271. Epub 2018 May 9.

Department of Medical Oncology, Gustave Roussy Cancer Campus, 114 rue Edouard-Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11096-018-0649-1
Publisher Site
http://dx.doi.org/10.1007/s11096-018-0649-1DOI Listing
October 2018

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 10 20;36(28):2872-2878. Epub 2018 Aug 20.

Matthew D. Hellmann, Parker Institute for Cancer Immunotherapy; Kathryn C. Arbour, Niamh Long, Hira Rizvi, Andy Ni, W. Victoria Lai, Joshua K. Sabari, Andrew J. Plodkowski, Darragh Halpenny, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Kathryn C. Arbour, W. Victoria Lai, Joshua K. Sabari, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Laura Mezquita, Roberto Ferrara, Lizza E.L. Hendriks, Caroline Caramella, Benjamin Besse, and David Planchard, Gustave Roussy Cancer Center, Villejuif; Edouard Auclin, Hôpital Européen Georges Pompidou; Benjamin Besse, Paris-Sud University, Le Kremlin Bicêtre, Paris, France; Gala Martínez-Bernal, Virgen del Rocío Hospital, Seville, Spain; Lizza E.L. Hendriks, Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0006DOI Listing
October 2018

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.

Lung Cancer 2018 09 27;123:14-21. Epub 2018 Apr 27.

Aix Marseille University, Jardin du Pharo, 58, bd Charles Livon, 13284 Marseille, France; Assistance Publique Hôpitaux de Marseille, 80, rue Brochier, 13005 Marseille, France; Centre d'Essais Précoces en Cancérologie de Marseille (CLIP(2)), Hôpital La Timone - Basement F, 1st Floor, 264, rue St Pierre, 13885 Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.04.022DOI Listing
September 2018

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.

Cancer Treat Rev 2018 Jul 31;68:69-79. Epub 2018 May 31.

Department of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, F-94805 Villejuif, France; Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.05.015DOI Listing
July 2018

Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?

J Surg Oncol 2018 Jun 24;117(7):1570-1574. Epub 2018 Mar 24.

Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris Sud University, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25042DOI Listing
June 2018

Do immune checkpoint inhibitors need new studies methodology?

J Thorac Dis 2018 May;10(Suppl 13):S1564-S1580

U.O.C. Oncology, University of Verona, Comprehensive Cancer Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.01.131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994495PMC
May 2018

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment.

Front Oncol 2018 11;8:88. Epub 2018 Apr 11.

Cancer Medicine Department, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904204PMC
April 2018

Progress in the Management of Advanced Thoracic Malignancies in 2017.

J Thorac Oncol 2018 03 11;13(3):301-322. Epub 2018 Jan 11.

Medical Oncology Department, Gustave Roussy, Villejuif, France; Cancer Medicine Department, University Paris-Saclay, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183000
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.01.002DOI Listing
March 2018

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Eur J Cancer 2018 03 10;91:21-29. Epub 2018 Jan 10.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276, Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276, Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265, Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.008DOI Listing
March 2018

Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 01 8;13(1):27-45. Epub 2017 Nov 8.

Medical Oncology Department, Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.021DOI Listing
January 2018

Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.

Support Care Cancer 2017 11 8;25(11):3365-3373. Epub 2017 Jun 8.

Département Ambulatoire, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3755-zDOI Listing
November 2017

Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?

Cancer Treat Rev 2017 Nov 24;60:60-68. Epub 2017 Aug 24.

Medical Oncology Department, Gustave Roussy, Villejuif, France; Paris-Sud University, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.08.003DOI Listing
November 2017

Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.

Eur J Cancer 2017 11 13;85:155-157. Epub 2017 Sep 13.

Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif, France; INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.07.049DOI Listing
November 2017

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Lung Cancer 2017 10 29;112:10-15. Epub 2017 Jul 29.

Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.004DOI Listing
October 2017

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Lung Cancer 2017 10 7;112:62-68. Epub 2017 Aug 7.

Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.002DOI Listing
October 2017

Peritoneal recurrence of thymoma treated by surgery and hyperthermic intraperitoneal chemotherapy.

Lung Cancer 2017 09 8;111:59-60. Epub 2017 Jul 8.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.06.011DOI Listing
September 2017

EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.

Pathol Res Pract 2017 Jul 30;213(7):793-798. Epub 2017 Mar 30.

Department of Medical Oncology, Gustave Roussy University Hospital, 114 rue Edouard Vaillant, 94805, Villejuif, France; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2017.03.011DOI Listing
July 2017

Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient.

Lung Cancer 2017 06 27;108:72-74. Epub 2017 Feb 27.

Department of Cancer Medicine, Gustave Roussy, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.022DOI Listing
June 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition.

Cancer Treat Rev 2017 Apr 12;55:83-95. Epub 2017 Mar 12.

Medical Oncology Unit, Univeristy Hospital of Parma, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.02.010DOI Listing
April 2017

[Thymic tumors].

Rev Prat 2017 04;67(4):430-434

Centre expert national pour la prise en charge des thymomes et carcinomes thymiques, RYTHMIC, Réseau tumeurs thymiques et cancer.

View Article

Download full-text PDF

Source
April 2017

Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.

Eur Radiol 2017 Mar 14;27(3):1211-1217. Epub 2016 Jun 14.

Department of Pathology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-016-4447-7DOI Listing
March 2017

Immune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer.

Curr Opin Oncol 2017 03;29(2):97-104

aGustave Roussy, Cancer Medicine Department, Villejuif bParis Sud University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000351DOI Listing
March 2017

Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung.

J Thorac Oncol 2017 01 17;12(1):e1-e3. Epub 2016 Aug 17.

Gustave Roussy, Paris-Saclay University, Medical Oncology Department, Villejuif, France; Paris-Sud University and Gustave Roussy Cancer Campus, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.124DOI Listing
January 2017

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.

J Thorac Oncol 2016 11 8;11(11):1819-1836. Epub 2016 Jun 8.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.027DOI Listing
November 2016

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104].

Lung Cancer 2016 11 6;101:146. Epub 2016 Oct 6.

Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.014DOI Listing
November 2016

Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw .

J Thorac Dis 2016 Nov;8(11):2997-3002

Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2016.11.76DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179464PMC
November 2016

Whole brain radiotherapy in patients with NSCLC and brain metastases.

Lancet 2016 Oct 4;388(10055):1960-1962. Epub 2016 Sep 4.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif 94800, France; Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31391-5DOI Listing
October 2016

Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options.

ESMO Open 2016 1;1(4):e000081. Epub 2016 Aug 1.

Medical Oncology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Paris Sud University, Orsay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070255PMC
August 2016

Disseminated intravascular coagulation following administration of sunitinib.

Mol Clin Oncol 2016 Jul 11;5(1):121-123. Epub 2016 May 11.

Internal Medicine and Clinical Immunology Department, Bicêtre Hospital, AP-HP, F-94270 Kremlin Bicêtre, France; Université Paris Sud, Kremlin Bicêtre, F-94270 Kremlin Bicêtre, France; Center for Immunology of Viral Infections and Autoimmune Diseases, F-92290 Chatenay-Malabry, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2016.896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906963PMC
July 2016